Samsung Biologics Revenue

In the year 2024, Samsung Biologics had annual revenue of 4.55T KRW with 23.08% growth. Samsung Biologics had revenue of 1.26T in the quarter ending December 31, 2024, with 17.04% growth.

Revenue

4,547.32B

Revenue Growth

+23.08%

P/S Ratio

16.72

Revenue / Employee

958.54M

Employees

4,744

Market Cap

76.01T

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	4,547.32B	852.73B	23.08%
Dec 31, 2023	3,694.59B	693.29B	23.10%
Dec 31, 2022	3,001.30B	1,433.29B	91.41%
Dec 31, 2021	1,568.01B	403.23B	34.62%
Dec 31, 2020	1,164.78B	463.19B	66.02%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Celltrion	2,876.25B
ALTEOGEN	74.38B
HLB Co., Ltd.	51.92B
Yuhan	2,008.84B
SK Biopharmaceuticals	511.33B
Sam Chun Dang Pharm.	208.22B
LigaChem Biosciences	101.42B
PharmaResearch	317.00B

Revenue Rankings